Swiss Policy Research: Ivermectin Debate

Later revised note: this website seems sketchy on later review.

• Studies in favor of ivermectin against covid tend to be considered "low quality" or haphazard
• Studies attempting to debunk ivermectin are fraudulent or equally low quality
• Large random trials claim ivermectin is not effective in the abstract, while demonstrating in the data an effect.
• The effect might be dose dependent, with some belief the dose must be very high, and some studies saying otherwise, but effective cases reduced mortality from 17-50% compared to other options.
• Ivermectin does not appear to block or destroy the virus but reduce the amount of damage it causes.
• Ivermectin use appears to be primarily beneficial for early treatment; not so much later cases.